Abstract: Synthetic lethality (SL) holds great promise as an emerging strategy of cancer therapy by selectively eliminating cancer cells. Despite wide adoption of high-throughput technologies for SL ...

What a result for Arno Merk. The German debutant defeats two-time World Champion Peter Wright in straight sets, dropping only two legs in the process! Republican warns Trump admin move "disastrous" ...

Merck & Co. is buying the developer of an experimental antiviral drug designed to prevent the flu, as the drugmaker aims to counter sales cliffs for two of its biggest drugs. Merck has been vocal ...

Drugmakers to cut prices on most drugs sold to the Medicaid program U.S. patients pay the most for prescription medicines Dec 19 (Reuters) - U.S. President Donald Trump and nine major pharmaceutical ...

Dec 19 (Reuters) - The U.S. Food and Drug Administration said on Friday it has granted national priority vouchers to Merck's (MRK.N), opens new tab cholesterol pill and its cancer therapy, making them ...

Pfizer has at least two key candidates in the pipeline that look like future winners. Merck has launched several products in preparation for a massive upcoming patent cliff. One of these drugmakers ...

Nine large pharma companies have reached agreements with the Trump administration to lower certain drug prices in the U.S. Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Gilead Sciences, GSK, ...

Editor's note: This article was updated at 320p ET to reflect a news conference at the White House with President Trump formally announcing the deals and providing additional details. The companies ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced a historic agreement with the Trump administration to ensure its prescription medicines are both accessible and ...

Merck & Co. is turning down its option to license Evaxion’s gonorrhea vaccine candidate, closing the door on the Danish biotech’s chance to collect up to $592 million in biobucks. Evaxion will now ...

LOWERING DRUG PRICES FOR AMERICAN PATIENTS: Today, President Donald J. Trump announced nine new agreements with major pharmaceutical companies to lower prescription drug prices for Americans in line ...